128 related articles for article (PubMed ID: 33835080)
21. Prognostic Implications of Synchronous Subsolid Nodules in Patients with Resected Subsolid Lung Adenocarcinoma.
Ahn Y; Lee SM; Choi S; Kim MJ; Choe J; Do KH; Seo JB
Radiology; 2023 Jul; 308(1):e230313. PubMed ID: 37462496
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
Zhang J; Liang ZY; Luo YF; Wan JW; Cao JL; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):651-6. PubMed ID: 20078967
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors of acinar- or papillary-predominant adenocarcinoma of the lung.
Kim M; Chung YS; Kim KA; Shim HS
Lung Cancer; 2019 Nov; 137():129-135. PubMed ID: 31586770
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension.
Lin MW; Wu CT; Shih JY; Chang YL; Yang PC
J Surg Oncol; 2014 Aug; 110(2):99-106. PubMed ID: 24788590
[TBL] [Abstract][Full Text] [Related]
26. Stromal micropapillary pattern and CD44s expression predict worse outcome in lung adenocarcinomas with micropapillary pattern.
Fu Y; Zha J; Wu Q; Tang Y; Wang W; Zhou Q; Jiang L
Pathol Res Pract; 2023 Aug; 248():154595. PubMed ID: 37343380
[TBL] [Abstract][Full Text] [Related]
27. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
[TBL] [Abstract][Full Text] [Related]
28. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
29. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.
Yeh YC; Kadota K; Nitadori J; Sima CS; Rizk NP; Jones DR; Travis WD; Adusumilli PS
Eur J Cardiothorac Surg; 2016 Jan; 49(1):e9-e15. PubMed ID: 26377636
[TBL] [Abstract][Full Text] [Related]
30. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
31. Pathologic Subtypes of Lung Adenocarcinoma Brain Metastasis Is a Strong Predictor of Survival After Resection.
Casteillo F; Guy JB; Dal-Col P; Karpathiou G; Pommier B; Bayle-Bleuez S; Fournel P; Vassal F; Forest F
Am J Surg Pathol; 2018 Dec; 42(12):1701-1707. PubMed ID: 30222604
[TBL] [Abstract][Full Text] [Related]
32. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma.
Hwang I; Park KU; Kwon KY
Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899
[TBL] [Abstract][Full Text] [Related]
33. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma.
Kim A; Lee SJ; Ahn J; Park WY; Shin DH; Lee CH; Kwon H; Jeong YJ; Ahn HY; I H; Kim YD; Cho JS
PLoS One; 2019; 14(11):e0224430. PubMed ID: 31743333
[TBL] [Abstract][Full Text] [Related]
35. Novel method for rapid identification of micropapillary or solid components in early-stage lung adenocarcinoma.
Zhao ZR; Lau RWH; Long H; Mok TSK; Chen GG; Underwood MJ; Ng CSH
J Thorac Cardiovasc Surg; 2018 Dec; 156(6):2310-2318.e2. PubMed ID: 30180981
[TBL] [Abstract][Full Text] [Related]
36. Recognition of filigree pattern expands the concept of micropapillary subtype in patients with surgically resected lung adenocarcinoma.
Zhu E; Xie H; Gu C; Su H; Zhao S; Ren Y; She Y; Zheng H; Xie D; Zhu Y; Jiang G; Wu C; Dai C; Chen C
Mod Pathol; 2021 May; 34(5):883-894. PubMed ID: 33199840
[TBL] [Abstract][Full Text] [Related]
37. Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients.
Chao L; Yi-Sheng H; Yu C; Li-Xu Y; Xin-Lan L; Dong-Lan L; Jie C; Yi-Lon W; Hui LY
Lung Cancer; 2014 Nov; 86(2):164-9. PubMed ID: 25236981
[TBL] [Abstract][Full Text] [Related]
38. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
39. Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.
Emoto K; Eguchi T; Tan KS; Takahashi Y; Aly RG; Rekhtman N; Travis WD; Adusumilli PS
J Thorac Oncol; 2019 Nov; 14(11):1948-1961. PubMed ID: 31352072
[TBL] [Abstract][Full Text] [Related]
40. Lung Adenocarcinomas Manifesting as Radiological Part-Solid Nodules Define a Special Clinical Subtype.
Ye T; Deng L; Wang S; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Xie L; Gu W; Zhao Y; Fu F; Peng W; Chen H
J Thorac Oncol; 2019 Apr; 14(4):617-627. PubMed ID: 30659988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
